168 related articles for article (PubMed ID: 37749132)
1. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.
Ying P; Chen C; Lu Z; Chen S; Zhang M; Cai Y; Zhang F; Huang J; Fan L; Ning C; Li Y; Wang W; Geng H; Liu Y; Tian W; Yang Z; Liu J; Huang C; Yang X; Xu B; Li H; Zhu X; Li N; Li B; Wei Y; Zhu Y; Tian J; Miao X
Nat Commun; 2023 Sep; 14(1):5958. PubMed ID: 37749132
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide enhancer maps link risk variants to disease genes.
Nasser J; Bergman DT; Fulco CP; Guckelberger P; Doughty BR; Patwardhan TA; Jones TR; Nguyen TH; Ulirsch JC; Lekschas F; Mualim K; Natri HM; Weeks EM; Munson G; Kane M; Kang HY; Cui A; Ray JP; Eisenhaure TM; Collins RL; Dey K; Pfister H; Price AL; Epstein CB; Kundaje A; Xavier RJ; Daly MJ; Huang H; Finucane HK; Hacohen N; Lander ES; Engreitz JM
Nature; 2021 May; 593(7858):238-243. PubMed ID: 33828297
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles.
Sakaue S; Weinand K; Isaac S; Dey KK; Jagadeesh K; Kanai M; Watts GFM; Zhu Z; ; Brenner MB; McDavid A; Donlin LT; Wei K; Price AL; Raychaudhuri S
Nat Genet; 2024 Apr; 56(4):615-626. PubMed ID: 38594305
[TBL] [Abstract][Full Text] [Related]
4. Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.
Tian J; Chang J; Gong J; Lou J; Fu M; Li J; Ke J; Zhu Y; Gong Y; Yang Y; Zou D; Peng X; Yang N; Mei S; Wang X; Zhong R; Cai K; Miao X
Am J Hum Genet; 2019 Jul; 105(1):29-47. PubMed ID: 31204011
[TBL] [Abstract][Full Text] [Related]
5. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both
Tian J; Lou J; Cai Y; Rao M; Lu Z; Zhu Y; Zou D; Peng X; Wang H; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Cancer Res; 2020 May; 80(9):1804-1818. PubMed ID: 32127356
[TBL] [Abstract][Full Text] [Related]
6. Prioritization of risk genes in colorectal cancer by integrative analysis of multi-omics data and gene networks.
Zhang M; Wang X; Yang N; Zhu X; Lu Z; Cai Y; Li B; Zhu Y; Li X; Wei Y; Zhang S; Tian J; Miao X
Sci China Life Sci; 2024 Jan; 67(1):132-148. PubMed ID: 37747674
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
8. A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer.
Chang J; Tian J; Yang Y; Zhong R; Li J; Zhai K; Ke J; Lou J; Chen W; Zhu B; Shen N; Zhang Y; Gong Y; Zhu Y; Zou D; Peng X; Huang K; Miao X
Cancer Res; 2018 Sep; 78(17):5164-5172. PubMed ID: 30026326
[TBL] [Abstract][Full Text] [Related]
9. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
[TBL] [Abstract][Full Text] [Related]
10. HSPA12A was identified as a key driver in colorectal cancer GWAS loci 10q26.12 and modulated by an enhancer-promoter interaction.
Lu Z; Fan L; Zhang F; Huang C; Cai Y; Chen C; Li G; Zhang M; Huang J; Ning C; Li Y; Wang W; Geng H; Liu Y; Chen S; Li H; Yang S; Zhang H; Tian W; Ye T; Liu J; Yang X; Xu B; Zhu Y; Zhong R; Li H; Tian J; Li B; Miao X
Arch Toxicol; 2023 Jul; 97(7):2015-2028. PubMed ID: 37245169
[TBL] [Abstract][Full Text] [Related]
11. Fine-mapping of Parkinson's disease susceptibility loci identifies putative causal variants.
Schilder BM; Raj T
Hum Mol Genet; 2022 Mar; 31(6):888-900. PubMed ID: 34617105
[TBL] [Abstract][Full Text] [Related]
12. Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a
Rosier F; Brisebarre A; Dupuis C; Baaklini S; Puthier D; Brun C; Pradel LC; Rihet P; Payen D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072601
[TBL] [Abstract][Full Text] [Related]
13. Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits.
Wang M; Hancock TP; MacLeod IM; Pryce JE; Cocks BG; Hayes BJ
Genet Sel Evol; 2017 Jul; 49(1):56. PubMed ID: 28683716
[TBL] [Abstract][Full Text] [Related]
14.
Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
[TBL] [Abstract][Full Text] [Related]
15. An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element.
Clop A; Bertoni A; Spain SL; Simpson MA; Pullabhatla V; Tonda R; Hundhausen C; Di Meglio P; De Jong P; Hayday AC; Nestle FO; Barker JN; Bell RJ; Capon F; Trembath RC
PLoS One; 2013; 8(8):e71690. PubMed ID: 23990973
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
17. Integrative functional analysis of super enhancer SNPs for coronary artery disease.
Gong J; Qiu C; Huang D; Zhang Y; Yu S; Zeng C
J Hum Genet; 2018 May; 63(5):627-638. PubMed ID: 29491472
[TBL] [Abstract][Full Text] [Related]
18. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
19. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
20. Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders.
Jeng MY; Mumbach MR; Granja JM; Satpathy AT; Chang HY; Chang ALS
J Invest Dermatol; 2019 Mar; 139(3):605-614. PubMed ID: 30315781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
